Edward Sturchio
General Counsel bij IMMATICS N.V.
Vermogen: 1 M $ op 31-03-2024
Profiel
Edward Sturchio is currently the General Counsel at Immatics NV since 2020.
Prior to this, he worked as the Secretary, Senior Vice President & General Counsel at Abeona Therapeutics, Inc. from 2019 to 2020, and as the Secretary & Global General Counsel at Advanced Accelerator Applications SA from 2016 to 2018.
He completed his undergraduate degree at Villanova University and his graduate degree at Seton Hall University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMATICS N.V.
0.10% | 31-01-2024 | 106 875 ( 0.10% ) | 1 M $ | 31-03-2024 |
Actieve functies van Edward Sturchio
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMATICS N.V. | General Counsel | 01-06-2020 |
Eerdere bekende functies van Edward Sturchio
| Bedrijven | Functie | Einde |
|---|---|---|
| ABEONA THERAPEUTICS INC. | General Counsel | 01-02-2020 |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | General Counsel | 01-08-2018 |
Opleiding van Edward Sturchio
| Villanova University | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| IMMATICS N.V. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
